Drug Database
LA

lansoprazole + amoxicillin + clarithromycin (Lansap)

✓ Approved

Takeda · ATP4A · Small Molecule

What is lansoprazole + amoxicillin + clarithromycin?

lansoprazole + amoxicillin + clarithromycin is a small molecule developed by Takeda. It is approved for therapeutic indications via oral (po).

Drug Profile

Brand NamesLansap
CompanyTakeda
Drug ClassSmall Molecule
Molecular TargetATP4A
RouteOral (PO)
StatusApproved

Mechanism of Action

Molecular Targets

lansoprazole + amoxicillin + clarithromycin acts on 1 molecular target:

ATP4AATPase H+/K+ transporting subunit alpha (ATP6A)
Want deeper analysis?Noah AI can explain complex mechanisms and compare to similar drugs.

Therapeutic Indications

lansoprazole + amoxicillin + clarithromycin is developed for 2 unique indications across 2 therapeutic areas.

Therapeutic AreaConditionPhase
Gastrointestinal disordersGastric ulcer✓ Approved
Infections and infestationsHelicobacter infection✓ Approved

Related Research Articles

PubMedJournal of medical case reports2026-09-19

Like father, like daughter: amoxicillin-induced aseptic meningitis in a female patient and her father: a case report.

Farhood Ibrahim I, Seidel Sabine S, Kaeder Maximilian M, Schönlau Lars L et al.

Drug-induced aseptic meningitis (DIAM) is a neurological disorder that requires specialized diagnostic pathways and an in-depth patient history to prevent inaccurate diagnoses and unnecessary procedures. Amoxicillin has been reported as one of the drugs causing recurrent DIAM, with a total of 22 patients described in the literature. We report two cases involving patients of Mediterranean ethnicity -a father (69-years-old) and his daughter (47-years-old)-who presented to our neurology department at different time points with severe headache persisting for several days. Both patients disclosed recent use of amoxicillin to treat bronchitis and otitis. In both cases, examination of cerebrospinal fluid (CSF) revealed leukocytosis with lymphocytic predominance, while no causative pathogens were identified. After extensive investigations to rule out other causes of secondary headache, a diagnosis of amoxicillin-induced aseptic meningitis (AIAM) was established. Notably, the daughter experienced two similar episodes, both temporally associated with amoxicillin intake. Amoxicillin-induced aseptic meningitis is a rare adverse reaction that should be considered in patients presenting with severe headache in the absence of an identifiable pathogen. A thorough patient history combined with comprehensive diagnostic evaluation is essential to establish the diagnosis and to avoid unnecessary or excessive treatment. Additionally, potential genetic predispositions, as suggested in other forms of drug-induced aseptic meningitis, may play a role and should be considered in selected cases.

PubMedThe American journal of case reports2026-09-19

Campylobacter jejuni as a Rare Pathogen in CIED Pocket Infections: A Case Report and Literature Review.

Barańska-Pawełczak Karolina K, Ziaja Bettina B, Opara Mariusz M, Jacheć Wojciech W

BACKGROUND Cardiac implantable electronic device (CIED) infections are usually caused by gram-positive bacteria, whereas gram-negative pathogens are uncommon. CASE REPORT We report a case of pacemaker pocket infection caused by Campylobacter jejuni in an immunocompromised patient. The patient underwent uncomplicated dual-chamber pacemaker implantation for sick sinus syndrome. At the first scheduled follow-up, after receiving a diagnosis of primary central nervous system diffuse large B-cell lymphoma and beginning chemotherapy with corticosteroids, swelling and subcutaneous fluid accumulation over the device pocket were observed. There were no local inflammatory signs; the patient had no systemic symptoms or recent history of diarrhea, abdominal pain, nausea, vomiting, or other gastrointestinal symptoms. Inflammatory markers were mildly elevated. Device pocket aspiration yielded straw-colored serous fluid; cultures of pocket fluid and blood grew C. jejuni, prompting a change from empirical amoxicillin-clavulanate to targeted macrolide therapy (intravenous clarithromycin) based on antimicrobial susceptibility testing. Transesophageal echocardiography showed no vegetations on the leads. The entire pacing system (generator and leads) was extracted, and temporary pacing was provided. Inflammatory markers became normalized during continued antibiotic therapy. After clinical stabilization, a new dual-chamber pacemaker was implanted contralaterally. The patient was discharged without signs of persistent infection and remains under regular outpatient follow-up. CONCLUSIONS This case emphasizes that subtle pocket changes in immunocompromised patients may indicate CIED infection, even in the absence of systemic symptoms. The absence of gastrointestinal symptoms suggests silent Campylobacter bacteremia with secondary seeding of the device pocket. Early microbiological sampling, pathogen-directed antimicrobial therapy, and complete device removal remain essential for cure.

PubMedJournal of the American Veterinary Medical Association2026-09-19

Escherichia coli isolated from canine pyometra show decreased susceptibility to amoxicillin-clavulanic acid in dogs.

Fautz Zoe Z, Amato Nicole N, Windsor Rebecca R

To describe bacterial culture results and antimicrobial susceptibility patterns for dogs undergoing surgical treatment for pyometra. This retrospective study included dogs that underwent ovariohysterectomy at referral hospitals and had a positive bacterial culture of uterine fluid or histopathologic changes consistent with pyometra between January 2020 and December 2024. Data collected from medical records included clinical signs on presentation, hematological and biochemical abnormalities, aerobic and anaerobic bacterial isolates, antimicrobial susceptibility results, and peri- and postoperative antimicrobial administration. Prevalence of antimicrobial susceptibility was compared across select geographic regions and between Clinical and Laboratory Standards Institute (CLSI) susceptibility interpretation guideline editions. 278 dogs were included. Neutrophilia was identified in 74.2% of dogs. Only 1 bacterium was isolated in 88.8% of dogs, while 10.4% of cases were polymicrobial. Escherichia coli was the most common isolate (73.1%). Amoxicillin-clavulanic acid and enrofloxacin were prescribed postoperatively to 77.6% and 51.1% of dogs, respectively. Using CLSI VET01S edition 4, E coli susceptibility to amoxicillin-clavulanic acid and enrofloxacin was present in 30.3% and 96.9% of isolates, respectively. Reclassification using CLSI VET01S edition 7 resulted in lower susceptibility classifications in 9 of 10 antimicrobials evaluated, including reductions of 46.9% for amoxicillin-clavulanic acid and 3.1% for enrofloxacin. Amoxicillin-clavulanic acid was frequently prescribed despite limited susceptibility among E coli isolates. Updated CLSI breakpoints reclassified susceptibility for most antimicrobials despite unchanged MICs. Regional antibiograms may show decreased susceptibility compared to historical recommendations. Judicious empiric antimicrobial selection should be guided by antimicrobial stewardship principles rather than routine reliance on any single antimicrobial.

PubMedBMC infectious diseases2026-09-19

Comparable tolerability, symptom worsening, and treatment completion rates among different Helicobacter pylori eradication regimens in children.

Gürcan Kaya Neslihan N, Selbuz Suna S

The tolerability of Helicobacter pylori (H. pylori)eradication regimens in children remains a clinical concern, particularly regarding gastrointestinal adverse effects and treatment discontinuation. The aim of this study was to compare the tolerability of different H. pylori eradication regimens in children by evaluating treatment-related symptoms, symptom worsening during therapy, and treatment completion rates. Pediatric patients with endoscopically confirmed H. pylori infection were treated with clarithromycin-based, metronidazole-based, or bismuth-containing regimens. All eradication regimens were administered for 14 days. Symptom severity was graded using a standardized scoring system, and stool pattern was assessed using the Bristol Stool Scale. Symptom worsening was defined as an increase compared with baseline. Within-group comparisons were performed using the Wilcoxon signed-rank test, and between-group differences were analyzed using chi-square or Fisher's exact test. A p value < 0.05 was considered statistically significant. In the overall study population, nausea, vomiting, metalic taste and anorexia scores increased significantly during treatment compared with baseline (Wilcoxon signed-rank test, p < 0.05). However, symptom worsening rates and stool pattern changes did not differ significantly among treatment groups (all p > 0.05). A total of 16 patients discontinued therapy. Discontinuation rates were 9.1% in the clarithromycin-based group, 2.4% in the metronidazole-based group, and 12.0% in the bismuth-containing group, with no statistically significant difference between groups (p = 0.204). Vomiting was the most common reason for treatment interruption, followed by diarrhea. The evaluated H. pylori eradication regimens showed comparable tolerability and treatment completion rates in children. Treatment selection may therefore be guided primarily by eradication efficacy and antimicrobial resistance patterns rather than concerns regarding adverse effects alone.

PubMedBritish dental journal2026-09-19

Rethinking systemic adjuncts in periodontitis: a single centre acquisition cost comparison of antimicrobial and non-antimicrobial therapies.

Almanie Lina L, Neves Vitor C M VCM

Aims To compare National Health Service (NHS) acquisition costs of systemic antimicrobial regimens with emerging non-antimicrobial adjuncts in periodontal therapy and to model potential national financial implications.Methods A secondary acquisition cost comparison analysis was undertaken using three-year prescription data (2021-2024) from a service evaluation at Charles Clifford Dental Hospital. Antibiotic prescriptions were cross-referenced with clinical records to identify those issued for periodontitis. Direct acquisition costs were calculated using Sheffield Teaching Hospitals NHS Foundation Trust pricing.Results Of 643 antibiotic prescriptions, 445 (69.2%) were issued for periodontitis. Azithromycin accounted for 93.5% of periodontal prescriptions, whereas guideline-recommended amoxicillin plus metronidazole (A+M) represented 1.6%. Compared with A+M (£2.81 per course), azithromycin reduced acquisition costs by 55.16%. Non-antimicrobial adjuncts demonstrated substantially greater reductions depending on treatment duration, with metformin 500 mg achieving up to 91.46% reduction.Conclusions Non-antimicrobial systemic adjuncts demonstrate considerable direct cost advantages over traditional antimicrobial regimens. These findings highlight potential economic and antimicrobial stewardship benefits and support the need for formal cost-effectiveness analyses to inform future prescribing guidance.

PubMedInternational journal of veterinary science and medicine2026-09-19

Occurrence and Antimicrobial Resistance Profiles of Escherichia coli along the Sheep Meat Production Chain: A One Health Approach.

Sumaila Nafisah N, Adzitey Frederick F, Abu Alexander A, Monten Stephen K Kanten SKK et al.

Antimicrobial-resistant foodborne bacteria circulating among animals, humans, and the environment pose a significant threat to public health worldwide. This study investigated the occurrence and antimicrobial resistance profiles of E. coli along the sheep meat production chain using a One Health approach. A total of 224 samples were collected over a six-month period from sheep farms and meat processing environments. Isolation and confirmation of E. coli were performed using standard microbiological methods, and confirmed isolates were subjected to antimicrobial susceptibility testing against ten commonly used antibiotics. Overall, E. coli was detected in 35.7% (80/224) of the samples, with a significantly higher (P=0.018) occurrence in processing environments (42.9%, 48/112) than on farms (28.6%, 32/112). On farms, the occurrence of E. coli ranged from 0 to 81.3%, with faecal samples recording the highest prevalence, while no isolates were recovered from feed obtained from bulk storage. In processing environments, occurrence ranged from 12.5 to 68.8%, with processors' hand swabs exhibiting the highest contamination level and processing table swabs recording the lowest. Antimicrobial susceptibility testing revealed that farm-derived E. coli isolates exhibited the highest resistance to amoxicillin (57.7%) but remained highly susceptible (≥ 95) to chloramphenicol and sulfamethoxazole/trimethoprim. In contrast, isolates from processing environments showed the highest resistance to tetracycline (60.5%) and highest susceptibility to chloramphenicol (76.3%). Multiple antibiotic resistance (MAR) indices ranged from 0.0 to 0.7 among farm isolates and from 0.0 to 0.8 among isolates from processing environments, indicating varying levels of antimicrobial exposure and selection pressure along the production chain. The findings demonstrate that E. coli contamination occurs at multiple points along the sheep meat production chain, with processing environments serving as potential reservoirs for antimicrobial-resistant strains. The detection of multidrug-resistant E. coli across animal, human, and environmental interfaces highlights the interconnected nature of antimicrobial resistance and underscores the importance of the One Health approach in surveillance and control efforts. Strengthening hygiene and sanitation practices, together with promoting prudent antimicrobial use are essential to reducing the risk of foodborne infections and the dissemination of antimicrobial resistance within the sheep food production system.

+9996 more articles available with a free account

Sign up free to view all articles →

Ask about lansoprazole + amoxicillin + clarithromycin